Healthequity (HQY) Net Income towards Common Stockholders (2013 - 2026)

Healthequity's Net Income towards Common Stockholders history runs 14 years deep, the most recent figure standing at $69.4 million for Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders rose 28.66% year-over-year to $69.4 million; the TTM figure through Apr 2026 stood at $230.7 million (up 89.37% YoY), while the FY2026 annual figure was $215.2 million, up 122.54% from the prior year.
• Net Income towards Common Stockholders for Q2 2026 stood at $69.4 million, up from $49.8 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $69.4 million in Q2 2026, with the low at -$32.8 million in Q1 2022.
• The 5-year median for Net Income towards Common Stockholders is $20.5 million (2023), against an average of $21.0 million.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders sank 711.48% in 2022, then surged 12714.35% in 2024.
• Healthequity's Net Income towards Common Stockholders stood at -$1.6 million in 2022, then jumped by 994.15% to $14.7 million in 2023, then tumbled by 61.13% to $5.7 million in 2024, then surged by 806.4% to $51.7 million in 2025, then surged by 34.29% to $69.4 million in 2026.
• Business Quant data shows HQY's Net Income towards Common Stockholders at $69.4 million in Q2 2026, $49.8 million in Q1 2026, and $51.7 million in Q4 2025.